We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
-$38.5M
(-0.79%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
4.3%
Holding
618
New
24
Increased
289
Reduced
263
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$19.3M |
| 2 |
Bath & Body Works
BBWI
|
+$11.5M |
| 3 |
Chubb
CB
|
+$10.8M |
| 4 |
Upstart Holdings
UPST
|
+$10.5M |
| 5 |
AbbVie
ABBV
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$13.1M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.48M |
| 4 |
Reinsurance Group of America
RGA
|
+$7.02M |
| 5 |
XPO
XPO
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Healthcare | 16.68% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
ZTO Express
ZTO
$17.9B
| $4.54M | 0.09% |
148,200
-22,900
| -13% | -$657K |
|
452
Fortune Brands Innovations
FBIN
$6.06B
| $4.53M | 0.09% |
59,202
+2,457
| +4% | +$204K |
|
453
VF Corp
VFC
$5.89B
| $4.51M | 0.09% |
67,400
-24,500
| -27% | -$1.88M |
|
454
Stryker
SYK
$130B
| $4.51M | 0.09% |
17,100
+1,800
| +12% | +$481K |
|
455
Sun Life Financial
SLF
$45.4B
| $4.46M | 0.09% |
68,400
-33,100
| -33% | -$1.7M |
|
456
Liberty Media Series C
FWONK
$25.8B
| $4.42M | 0.09% |
88,845
+19,651
| +28% | +$930K |
|
457
MetLife
MET
$62.1B
| $4.41M | 0.09% |
71,400
+34,300
| +92% | +$2.06M |
|
458
ON Semiconductor
ON
$31.6B
| $4.37M | 0.09% |
95,500
+14,000
| +17% | +$598K |
|
459
Bank of America
BAC
$442B
| $4.35M | 0.09% |
102,400
+32,900
| +47% | +$1.33M |
|
460
Goldman Sachs
GS
$303B
| $4.31M | 0.09% |
11,400
+300
| +3% | +$117K |
|
461
Ford
F
$55.7B
| $4.31M | 0.09% |
304,200
-147,300
| -33% | -$2M |
|
462
Amazon
AMZN
$2.96T
| $4.27M | 0.09% |
26,000
-2,000
| -7% | -$345K |
|
463
Steel Dynamics
STLD
$37.6B
| $4.26M | 0.09% |
+72,900
| New | +$4.66M |
|
464
Clorox
CLX
$12.7B
| $4.24M | 0.09% |
25,600
-800
| -3% | -$138K |
|
465
Tencent Music
TME
$15.6B
| $4.24M | 0.09% |
584,800
+121,200
| +26% | +$1.19M |
|
|
PPLI
466
People Inc
PPLI
$3.1B
| $4.23M | 0.09% |
39,618
+8,533
| +27% | +$940K |
|
467
Fidelity National Information Services
FIS
$22.1B
| $4.22M | 0.09% |
34,700
-2,900
| -8% | -$389K |
|
468
Gildan
GIL
$10.6B
| $4.22M | 0.09% |
91,200
+45,800
| +101% | +$1.68M |
|
469
Mercado Libre
MELI
$92.3B
| $4.2M | 0.09% |
2,500
-1,200
| -32% | -$2.08M |
|
470
C.H. Robinson
CHRW
$17.5B
| $4.18M | 0.09% |
48,000
+2,500
| +5% | +$226K |
|
471
Trip.com Group
TCOM
$29.1B
| $4.18M | 0.09% |
135,800
-17,600
| -11% | -$506K |
|
472
Vulcan Materials
VMC
$36.9B
| $4.13M | 0.09% |
24,400
-5,100
| -17% | -$913K |
|
473
BorgWarner
BWA
$13.9B
| $4.11M | 0.08% |
108,147
-45,099
| -29% | -$1.79M |
|
474
XPeng
XPEV
$11.6B
| $4.11M | 0.08% |
115,600
-32,800
| -22% | -$1.3M |
|
475
Teva Pharmaceuticals
TEVA
$41.2B
| $4.08M | 0.08% |
418,700
-254,500
| -38% | -$2.38M |
|
Similar funds
NW
GGHC
FT
DM
GRQ
PCM
IC
NB
Andra AP-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Andra AP-fonden held 618 positions worth $4.86B, down 0.79% from $4.9B the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
Andra AP-fonden's Q3 2021 filing shows 24 new, 289 increased, 263 reduced and 21 closed positions. Its largest new stake was Analog Devices: 115,031 shares worth $19.3M. The largest sale was Alexion Pharmaceuticals, an estimated $22M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q3 2021 buy was Analog Devices: 115,031 shares worth $19.3M.
- Andra AP-fonden added most to Otis Worldwide in Q3 2021, an estimated $4.8M increase.
- Andra AP-fonden's biggest Q3 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $5.36M.
- Andra AP-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22M.
- Andra AP-fonden's ten largest holdings make up 4.3% of its $4.86B portfolio in Q3 2021.
- Andra AP-fonden opened 24 new positions and closed 21 in Q3 2021.
- Andra AP-fonden's portfolio value fell 0.79% quarter-over-quarter to $4.86B.
Based on Andra AP-fonden's 13F filing for Q3 2021, filed 12 Nov 2021.